Gilead Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	8,510	480	5,665	4,592	6,225
Depreciation & Amortization	2,760	2,767	2,693	2,103	2,050
Asset Writedown & Restructuring Costs	1,614	8,843	1,205	3,644	939
Loss (Gain) From Sale of Investments	-451	274	167	657	610
Stock-Based Compensation	894	835	766	637	635
Other Operating Activities	640	-1,491	-187	-798	436
Change in Accounts Receivable	-367	139	157	-406	313
Change in Inventory	-1,036	-426	-842	-310	11
Change in Accounts Payable	-132	290	-347	226	-118
Change in Income Taxes	-	-	-	-364	-361
Change in Other Net Operating Assets	-305	-151	497	-909	644
Operating Cash Flow	10,019	10,828	8,006	9,072	11,384
Operating Cash Flow Growth	-7.47%	35.25%	-11.75%	-20.31%	39.37%
Capital Expenditures	-563	-523	-585	-728	-579
Cash Acquisitions	-1,070	-4,840	-1,152	-1,797	-1,584
Investment in Securities	-3,163	1,856	-528	60	-987
Other Investing Activities	3	58	-	-1	19
Investing Cash Flow	-4,793	-3,449	-2,265	-2,466	-3,131
Long-Term Debt Issued	-	3,464	1,980	-	-
Long-Term Debt Repaid	-1,788	-1,970	-2,250	-1,500	-4,750
Net Debt Issued (Repaid)	-1,788	1,494	-270	-1,500	-4,750
Issuance of Common Stock	408	422	232	309	169
Repurchase of Common Stock	-1,922	-1,150	-1,000	-1,396	-546
Common Dividends Paid	-4,003	-3,918	-3,809	-3,709	-3,605
Other Financing Activities	-440	-281	-278	-173	-145
Financing Cash Flow	-7,745	-3,433	-5,125	-6,469	-8,877
Foreign Exchange Rate Adjustments	92	-40	57	-63	-35
Net Cash Flow	-2,427	3,906	673	74	-659
Free Cash Flow	9,456	10,305	7,421	8,344	10,805
Free Cash Flow Growth	-8.24%	38.86%	-11.06%	-22.78%	43.72%
Free Cash Flow Margin	32.12%	35.84%	27.37%	30.59%	39.57%
Free Cash Flow Per Share	7.54	8.21	5.90	6.61	8.56
Cash Interest Paid	1,036	951	891	907	979
Cash Income Tax Paid	3,215	2,779	3,990	3,136	2,509
Levered Free Cash Flow	7,541	10,131	8,497	6,935	10,203
Unlevered Free Cash Flow	8,181	10,741	9,087	7,520	10,829
Change in Working Capital	-3,948	-880	-2,303	-1,763	489

Source: S&P Global Market Intelligence. Standard template. Financial Sources.